A new procedure for testing equivalence in comparative bioavailability and other clinical trials

From MaRDI portal
Publication:3347166

DOI10.1080/03610928308828634zbMath0553.62097OpenAlexW2056430771MaRDI QIDQ3347166

Sharon Anderson, W. W. Hauck

Publication date: 1983

Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610928308828634




Related Items (21)

Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailabilityA multiple test for comparing two treatments with control: Interval hypotheses approachEquivalent stiffness after glycosaminoglycan depletion in tendon -- an ultra-structural finite element model and corresponding experimentsProbabilities and sample sizes for the two one-sided tests procedureOn optimal tests for general interval-hypothesesRobust and bootstrap testing procedures for bioequivalenceA more powerful familywise error control procedure for evaluating mean equivalenceAn unbiased test for the bioequivalence problemTesting equivalence in clinical trials using a new principle for constructing statistical testsOn level and powee of anderson and hauck's peocedure for testing equivalence in compative bioavailabilityThe emperor's new tests. (With comments and a rejoinder).Some general results on least favorable parameter configurations with special reference to equivalence testing and the range statisticInference for negativist theory using numerically computed rejection regionsCross-over trials in drug development: Theory and practiceLikelihood Ratio Tests for the Non Equivalence of MeansHypothesis Testing for Equivalence Defined on Symmetric Open IntervalsBioequivalence and intrasubject variabilityOptimal testing of equivalence hypothesesNegligible interaction test for continuous predictorsRobustness of bioequivalence procedures under box-cox alternativesCLINICAL EQUIVALENCE



Cites Work


This page was built for publication: A new procedure for testing equivalence in comparative bioavailability and other clinical trials